The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
Open accessAbstract
Soon after they were first described in 1990, aptamers were largely recognized as a new class of biological ligands that can rival antibodies in various analytical, diagnostic, and therapeutic applications. Aptamers are short single-stranded RNA or DNA oligonucleotides capable of folding into complex 3D structures, enabling them to bind to a large variety of targets ranging from small ions to an entire organism. Their high binding specificity and affinity make them comparable to antibodies, but they are superior regarding a longer shelf life, simple production and chemical modification, in addition to low toxicity and immunogenicity. In the past three decades, aptamers have been used in a plethora of therapeutics and drug delivery systems that involve innovative delivery mechanisms and carrying various types of drug cargos. However, the successful translation of aptamer research from bench to bedside has been challenged by several limitations that slow down the realization of promising aptamer applications as therapeutics at the clinical level. The main limitations include the susceptibility to degradation by nucleases, fast renal clearance, low thermal stability, and the limited functional group diversity. The solution to overcome such limitations lies in the chemistry of aptamers. The current review will focus on the recent arts of aptamer chemistry that have been evolved to refine the pharmacological properties of aptamers. Moreover, this review will analyze the advantages and disadvantages of such chemical modifications and how they impact the pharmacological properties of aptamers. Finally, this review will summarize the conjugation strategies of aptamers to nanocarriers for developing targeted drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
Gao, S., Wu, Ding, Gao, Wang, Fan, Wang, Zhang, Wang, Ye, et al. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s23747 · Cited by 111
RetractedIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Hopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Rapid Spine Delivery and Redistribution of AMPA Receptors After Synaptic NMDA Receptor Activation
Shi, S.-H., Hayashi, Y., Petralia, R. S., Zaman, S. H., Wenthold, R. J., Svoboda, K., & Malinow, R. (1999) · Science · doi:10.1126/science.284.5421.1811 · Cited by 1,276
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
El-Sagheer, A. H., & Brown, T. (2010) · Chemical Society Reviews · doi:10.1039/b901971p · Cited by 739
Quantifying thiol–gold interactions towards the efficient strength control
Xue, Y., Li, X., Li, H., & Zhang, W. (2014) · Nature Communications · doi:10.1038/ncomms5348 · Cited by 738
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelova, S., Gbelcova, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 702
Recent Advances in Aptamer Discovery and Applications
Zhang, Y., Lai, B. S., & Juhas, M. (2019) · Molecules · doi:10.3390/molecules24050941 · Cited by 663
Obika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
Nimjee, S. M., White, R. R., Becker, R. C., & Sullenger, B. A. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104558 · Cited by 607
Zhang, X., Servos, M. R., & Liu, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3014055 · Cited by 593
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 566
Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Kimoto, M., Yamashige, R., Matsunaga, K.-I., Yokoyama, S., & Hirao, I. (2013) · Nature Biotechnology · doi:10.1038/nbt.2556 · Cited by 510
AVIDIN. 1. THE USE OF [14C]BIOTIN FOR KINETIC STUDIES AND FOR ASSAY
GREEN, N. (1963) · Biochemical Journal · doi:10.1042/bj0890585 · Cited by 482
Swayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 469
Polymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles
Yang, X., Liu, X., Liu, Z., Pu, F., Ren, J., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104797 · Cited by 424
Copper‐Catalyzed Azide–Alkyne Click Chemistry for Bioconjugation
Presolski, S. I., Hong, V. P., & Finn, M. G. (2011) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110148 · Cited by 416
THE EYETECH STUDY GROUP (2002) · Retina · doi:10.1097/00006982-200204000-00002 · Cited by 415
Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372
Wang, J., Zhu, G., You, M., Song, E., Shukoor, M. I., Zhang, K., Altman, M. B., Chen, Y., Zhu, Z., Huang, C. Z., et al. (2012) · ACS Nano · doi:10.1021/nn300694v · Cited by 357
Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
Ni, X., Castanares, M., Mukherjee, A., & Lupold, S. E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189600 · Cited by 349
[15] Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method
Caruthers, M. H., Barone, A. D., Beaucage, S. L., Dodds, D. R., Fisher, E. F., McBride, L. J., Matteucci, M., Stabinsky, Z., & Tang, J.-Y. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)54081-2 · Cited by 344
In vitro selection with artificial expanded genetic information systems
Sefah, K., Yang, Z., Bradley, K. M., Hoshika, S., Jiménez, E., Zhang, L., Zhu, G., Shanker, S., Yu, F., Turek, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311778111 · Cited by 330
DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells
Wu, Y., Sefah, K., Liu, H., Wang, R., & Tan, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909611107 · Cited by 330
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
Hicke, B. J., Marion, C., Chang, Y.-F., Gould, T., Lynott, C. K., Parma, D., Schmidt, P. G., & Warren, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104651200 · Cited by 324
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy
Chang, M., Yang, C.-S., & Huang, D.-M. (2011) · ACS Nano · doi:10.1021/nn200693a · Cited by 318
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
Savla, R., Taratula, O., Garbuzenko, O., & Minko, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.015 · Cited by 314
Expanding the Chemistry of DNA for in Vitro Selection
Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K., & Eaton, B. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908035g · Cited by 313
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
Huang, Y.-F., Chang, H.-T., & Tan, W. (2008) · Analytical Chemistry · doi:10.1021/ac702322j · Cited by 303
Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Hathout, Y., Brody, E., Clemens, P. R., Cripe, L., DeLisle, R. K., Furlong, P., Gordish-Dressman, H., Hache, L., Henricson, E., Hoffman, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507719112 · Cited by 290
Li, L., Hou, J., Liu, X., Guo, Y., Wu, Y., Zhang, L., & Yang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.019 · Cited by 289
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., Jucker, F. M., & Janjić, N. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90032-2 · Cited by 284
Campbell, M. A., & Wengel, J. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15048k · Cited by 279
Aptamers and the next generation of diagnostic reagents
Thiviyanathan, V., & Gorenstein, D. G. (2012) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201200042 · Cited by 275
Ganson, N. J., Povsic, T. J., Sullenger, B. A., Alexander, J. H., Zelenkofske, S. L., Sailstad, J. M., Rusconi, C. P., & Hershfield, M. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.034 · Cited by 273
Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration
D’Amico, D. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.027 · Cited by 260
Sacca, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki257 · Cited by 259
Hoellenriegel, J., Zboralski, D., Maasch, C., Rosin, N. Y., Wierda, W. G., Keating, M. J., Kruschinski, A., & Burger, J. A. (2014) · Blood · doi:10.1182/blood-2013-03-493924 · Cited by 242
Methods for Improving Aptamer Binding Affinity
Hasegawa, H., Savory, N., Abe, K., & Ikebukuro, K. (2016) · Molecules · doi:10.3390/molecules21040421 · Cited by 241
Yang, L., Tseng, Y.-T., Suo, G., Chen, L., Yu, J., Chiu, W.-J., Huang, C.-C., & Lin, C.-H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508117e · Cited by 240
Selective Photothermal Therapy for Mixed Cancer Cells Using Aptamer-Conjugated Nanorods
Huang, Y.-F., Sefah, K., Bamrungsap, S., Chang, H.-T., & Tan, W. (2008) · Langmuir · doi:10.1021/la801969c · Cited by 234
Release of Photoactivatable Drugs from Plasmonic Nanoparticles for Targeted Cancer Therapy
Luo, Y.-L., Shiao, Y.-S., & Huang, Y.-F. (2011) · ACS Nano · doi:10.1021/nn201592s · Cited by 233
Fan, Z., Shelton, M., Singh, A. K., Senapati, D., Khan, S. A., & Ray, P. C. (2012) · ACS Nano · doi:10.1021/nn2045246 · Cited by 228
Yu, M. K., Kim, D., Lee, I., So, J., Jeong, Y. Y., & Jon, S. (2011) · Small · doi:10.1002/smll.201100472 · Cited by 225
Click Nucleic Acid Ligation: Applications in Biology and Nanotechnology
El-Sagheer, A. H., & Brown, T. (2012) · Accounts of Chemical Research · doi:10.1021/ar200321n · Cited by 223
Xu, W., Siddiqui, I. A., Nihal, M., Pilla, S., Rosenthal, K., Mukhtar, H., & Gong, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.006 · Cited by 223
Circular Bivalent Aptamers Enable in Vivo Stability and Recognition
Kuai, H., Zhao, Z., Mo, L., Liu, H., Hu, X., Fu, T., Zhang, X., & Tan, W. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04547 · Cited by 222
Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor
Pagratis, N. C., Bell, C., Chang, Y.-F., Jennings, S., Fitzwater, T., Jellinek, D., & Dang, C. (1997) · Nature Biotechnology · doi:10.1038/nbt0197-68 · Cited by 221
Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor
Jellinek, D., Green, L. S., Bell, C., Lynott, C. K., Gill, N., Vargeese, C., Kirschenheuter, G., McGee, D. P. C., & Abesinghe, P. (1995) · Biochemistry · doi:10.1021/bi00036a009 · Cited by 215
In vivo SELEX for Identification of Brain-penetrating Aptamers
Cheng, C., Chen, Y. H., Lennox, K. A., Behlke, M. A., & Davidson, B. L. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.59 · Cited by 214
Dual-Surface Modified Virus Capsids for Targeted Delivery of Photodynamic Agents to Cancer Cells
Stephanopoulos, N., Tong, G. J., Hsiao, S. C., & Francis, M. B. (2010) · ACS Nano · doi:10.1021/nn1014769 · Cited by 211
Drolet, D. W., Nelson, J., Tucker, C. E., Zack, P. M., Nixon, K., Bolin, R., Judkins, M. B., Farmer, J. A., Wolf, J. L., Gill, S. C., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007657109012 · Cited by 206
Deng, K., Hou, Z., Li, X., Li, C., Zhang, Y., Deng, X., Cheng, Z., & Lin, J. (2015) · Scientific Reports · doi:10.1038/srep07851 · Cited by 206
Inhibition of Cell Proliferation by an Anti-EGFR Aptamer
Li, N., Nguyen, H. H., Byrom, M., & Ellington, A. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020299 · Cited by 205
Henry, S. P., Giclas, P. C., Leeds, J., Pangburn, M., Auletta, C., Levin, A. A., & Kornbrust, D. J. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36667-4 · Cited by 204
Tao, W., Zeng, X., Wu, J., Zhu, X., Yu, X., Zhang, X., Zhang, J., Liu, G., & Mei, L. (2016) · Theranostics · doi:10.7150/thno.14184 · Cited by 203
Latham, J. A., Johnson, R., & Toole, J. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.14.2817 · Cited by 200
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
Alshaer, W., Hillaireau, H., Vergnaud, J., Ismail, S., & Fattal, E. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5004313 · Cited by 200
Self-citationXing, H., Tang, L., Yang, X., Hwang, K., Wang, W., Yin, Q., Wong, N. Y., Dobrucki, L. W., Yasui, N., Katzenellenbogen, J. A., et al. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20412j · Cited by 199
Selection of DNA aptamers with two modified bases
Gawande, B. N., Rohloff, J. C., Carter, J. D., von Carlowitz, I., Zhang, C., Schneider, D. J., & Janjic, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615475114 · Cited by 194
AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery
Aravind, A., Jeyamohan, P., Nair, R., Veeranarayanan, S., Nagaoka, Y., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24558 · Cited by 191
Yu, C., Hu, Y., Duan, J., Yuan, W., Wang, C., Xu, H., & Yang, X.-D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024077 · Cited by 190
Wilds, C. J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3625 · Cited by 188
Aptamer-guided nanomedicines for anticancer drug delivery
Alshaer, W., Hillaireau, H., & Fattal, E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.011 · Cited by 187
Self-citationAptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis
Wang, C.-H., Kang, S.-T., Lee, Y.-H., Luo, Y.-L., Huang, Y.-F., & Yeh, C.-K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.036 · Cited by 185
Xie, X., Li, F., Zhang, H., Lu, Y., Lian, S., Lin, H., Gao, Y., & Jia, L. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.014 · Cited by 185
Martínez-Jothar, L., Doulkeridou, S., Schiffelers, R. M., Sastre Torano, J., Oliveira, S., van Nostrum, C. F., & Hennink, W. E. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.002 · Cited by 185
Wlotzka, B., Leva, S., Eschgfäller, B., Burmeister, J., Kleinjung, F., Kaduk, C., Muhn, P., Hess-Stumpp, H., & Klussmann, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132067399 · Cited by 183
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
Esposito, C. L., Passaro, D., Longobardo, I., Condorelli, G., Marotta, P., Affuso, A., de Franciscis, V., & Cerchia, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024071 · Cited by 182
Modified RNA sequence pools for in vitro selection
Lin, Y., Qiu, Q., Gill, S. C., & Jayasena, S. D. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.24.5229 · Cited by 182
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Burdick, A. D., Sciabola, S., Mantena, S. R., Hollingshead, B. D., Stanton, R., Warneke, J. A., Zeng, M., Martsen, E., Medvedev, A., Makarov, S. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku142 · Cited by 178
Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer
Pasternak, A., Hernandez, F. J., Rasmussen, L. M., Vester, B., & Wengel, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq823 · Cited by 177
Effect of Chemical Modifications on Aptamer Stability in Serum
Kratschmer, C., & Levy, M. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0680 · Cited by 177
Zhang, H., Ma, Y., Xie, Y., An, Y., Huang, Y., Zhu, Z., & Yang, C. J. (2015) · Scientific Reports · doi:10.1038/srep10099 · Cited by 174
G-quadruplex-based aptamers against protein targets in therapy and diagnostics
Platella, C., Riccardi, C., Montesarchio, D., Roviello, G. N., & Musumeci, D. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.027 · Cited by 170
A liposome-based nanostructure for aptamer directed delivery
Kang, H., O’Donoghue, M. B., Liu, H., & Tan, W. (2010) · Chem. Commun. · doi:10.1039/b916911c · Cited by 169
Xiang, D., Shigdar, S., Yang, W., Duan, W., Li, Q., Lin, J., Liu, K., & Li, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s59779 · Cited by 167
Azhdarzadeh, M., Atyabi, F., Saei, A. A., Varnamkhasti, B. S., Omidi, Y., Fateh, M., Ghavami, M., Shanehsazzadeh, S., & Dinarvand, R. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.02.058 · Cited by 163
Alibolandi, M., Taghdisi, S. M., Ramezani, P., Hosseini Shamili, F., Farzad, S. A., Abnous, K., & Ramezani, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.044 · Cited by 162
Shoji, A., Kuwahara, M., Ozaki, H., & Sawai, H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067098n · Cited by 161
Identification of an aptamer targeting hnRNP A1 by tissue slide‐based SELEX
Li, S., Xu, H., Ding, H., Huang, Y., Cao, X., Yang, G., Li, J., Xie, Z., Meng, Y., Li, X., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2543 · Cited by 161
Taghdisi, S. M., Lavaee, P., Ramezani, M., & Abnous, K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.005 · Cited by 157
Xiao, Z., Levy‐Nissenbaum, E., Alexis, F., Lupták, A., Teply, B. A., Chan, J. M., Shi, J., Digga, E., Cheng, J. W. M., Langer, R., et al. (2012) · ACS Nano · doi:10.1021/nn204165v · Cited by 157
de Smidt, P. C., Doan, T. L., Falco, S. D., et al. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.17.4695 · Cited by 155
Padilla, R. M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1561 · Cited by 154
Hocek, M. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo5020799 · Cited by 153
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
Prodeus, A., Abdul‐Wahid, A., Fischer, N. W., Huang, E. H. ‐., Cydzik, M., & Gariépy, J. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.11 · Cited by 151
Baek, S. E., Lee, K. H., Park, Y. S., Oh, D., Oh, S., Kim, K., & Kim, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.018 · Cited by 148
Alshaer, W., Hillaireau, H., Vergnaud, J., Mura, S., Deloménie, C., Sauvage, F., Ismail, S. I., & Fattal, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.022 · Cited by 147
Self-citationA polyvalent aptamer system for targeted drug delivery
Zhang, Z., Ali, M. M., Eckert, M. A., Kang, D., Chen, Y. Y., Sender, L. S., Fruman, D. A., & Zhao, W. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.079 · Cited by 146
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146
Liao, Z., Chuang, E., Lin, C.-C., Ho, Y., Lin, K., Cheng, P., Chen, K., Wei, H.-J., & Sung, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.032 · Cited by 145
Taghavi, S., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.008 · Cited by 145
A dimerization-based fluorogenic dye-aptamer module for RNA imaging in live cells
Bouhedda, F., Fam, K. T., Collot, M., Autour, A., Marzi, S., Klymchenko, A. S., & Ryckelynck, M. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0381-8 · Cited by 145
Waters, E. K., Genga, R. M. J., Schwartz, M. C., Nelson, J. A., Schaub, R. G., Olson, K. A., Kurz, J. C., & McGinness, K. E. (2011) · Blood · doi:10.1182/blood-2010-10-311936 · Cited by 143
Mastico, R. A., Talbot, S. J., & Stockley, P. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-4-541 · Cited by 142
Selecting Aptamers for a Glycoprotein through the Incorporation of the Boronic Acid Moiety
Li, M., Lin, N., Huang, Z., Du, L., Altier, C., Fang, H., & Wang, B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801510d · Cited by 139
Taghdisi, S. M., Danesh, N. M., Ramezani, M., Lavaee, P., Jalalian, S. H., Robati, R. Y., & Abnous, K. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.03.013 · Cited by 139
Molecular Evolution of Functional Nucleic Acids with Chemical Modifications
Kuwahara, M., & Sugimoto, N. (2010) · Molecules · doi:10.3390/molecules15085423 · Cited by 136
Li, X., Yang, Y. L., Ji, Q., & Qiu, L. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.013 · Cited by 136
Tong, R., Yala, L., Fan, T. M., & Cheng, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.009 · Cited by 135
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier
Monaco, I., Camorani, S., Colecchia, D., Locatelli, E., Calandro, P., Oudin, A., Niclou, S. P., Arra, C., Chiariello, M., Cerchia, L., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00527 · Cited by 134
Alibolandi, M., Ramezani, M., Sadeghi, F., Abnous, K., & Hadizadeh, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.035 · Cited by 133
Smart Multifunctional Nanostructure for Targeted Cancer Chemotherapy and Magnetic Resonance Imaging
Chen, T., Shukoor, M. I., Wang, R., Zhao, Z., Yuan, Q., Bamrungsap, S., Xiong, X., & Tan, W. (2011) · ACS Nano · doi:10.1021/nn202073m · Cited by 133
Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery
Charoenphol, P., & Bermudez, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500047b · Cited by 132
Zhang, C., Ji, X., Zhang, Y., Zhou, G., Ke, X., Wang, H., Tinnefeld, P., & He, Z. (2013) · Analytical Chemistry · doi:10.1021/ac400606e · Cited by 130
Synthetic Aptamer-Polymer Hybrid Constructs for Programmed Drug Delivery into Specific Target Cells
Oh, S. S., Lee, B. F., Leibfarth, F. A., Eisenstein, M. S., Robb, M. J., Lynd, N. A., Hawker, C. J., & Soh, H. T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5079464 · Cited by 128
Recent developments in cell-SELEX technology for aptamer selection
Kaur, H. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.07.029 · Cited by 128
Yu, Z., Ni, M., Xiong, M., Zhang, X., Cai, G., Chen, H., & Zeng, Q. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s78498 · Cited by 127
Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates
Lee, I., An, S., Yu, M. K., Kwon, H., Im, S., & Jon, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.025 · Cited by 126
Shum, K. T., & Tanner, J. A. (2008) · ChemBioChem · doi:10.1002/cbic.200800491 · Cited by 125
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
Abeydeera, N., Egli, M., Cox, N., Mercier, K., Conde, J. N., Pallan, P. S., Mizurini, D. M., Sierant, M., Hibti, F.-E., Hassell, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw725 · Cited by 122
Generation of Aptamers with an Expanded Chemical Repertoire
Diafa, S., & Hollenstein, M. (2015) · Molecules · doi:10.3390/molecules200916643 · Cited by 120
Polyvalent Mesoporous Silica Nanoparticle‐Aptamer Bioconjugates Target Breast Cancer Cells
Li, L., Yin, Q., Cheng, J., & Lu, Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200116 · Cited by 115
Oxidative coupling of peptides to a virus capsid containing unnatural amino acids
Carrico, Z. M., Romanini, D. W., Mehl, R. A., & Francis, M. B. (2008) · Chemical Communications · doi:10.1039/b717826c · Cited by 114
Bandekar, A., Zhu, C., Jindal, R., Bruchertseifer, F., Morgenstern, A., & Sofou, S. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.125476 · Cited by 113
Das, M., Duan, W., & Sahoo, S. K. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.002 · Cited by 112
Aptamer-Functionalized Gold Nanoparticles As Photoresponsive Nanoplatform for Co-Drug Delivery
Shiao, Y.-S., Chiu, H.-H., Wu, P.-H., & Huang, Y. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5026243 · Cited by 112
Wang, K., Yao, H., Meng, Y., Wang, Y., Yan, X., & Huang, R. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.01.002 · Cited by 107
Carbodiimide Induced Cross-Linking, Ligand Addition, and Degradation in Gelatin
Cammarata, C. R., Hughes, M. E., & Ofner, C. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006118 · Cited by 107
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX
Dong, L., Tan, Q., Ye, W., Liu, D., Chen, H., Hu, H., Wen, D., Liu, Y., Cao, Y., Kang, J., et al. (2015) · Scientific Reports · doi:10.1038/srep15552 · Cited by 107
Mann, A. P., Somasunderam, A., Nieves-Alicea, R., Li, X., Hu, A. H., Sood, A. K., Mauro Ferrari, B., Gorenstein, D. G., & Tanaka, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013050 · Cited by 106
Efficacy of Base-Modification on Target Binding of Small Molecule DNA Aptamers
Imaizumi, Y., Kasahara, Y., Fujita, H., Kitadume, S., Ozaki, H., Endoh, T., Kuwahara, M., & Sugimoto, N. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4012222 · Cited by 106
Lee, C. H., Lee, S.-H., Kim, J. H., Noh, Y.-H., Noh, G., & Lee, S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.30 · Cited by 106
Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
Somasunderam, A., Thiviyanathan, V., Tanaka, T., Li, X., Neerathilingam, M., Lokesh, G. L.-R., Mann, A. P., Peng, Y., Mauro Ferrari, B., Klostergaard, J., et al. (2010) · Biochemistry · doi:10.1021/bi1009503 · Cited by 103
New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX
Kato, Y., Minakawa, N., Komatsu, Y., Kamiya, H., Ogawa, N., Harashima, H., & Matsuda, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki578 · Cited by 101
Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer
Powell, D., Chandra, S., Dodson, K., Shaheen, F., Wiltz, K., Ireland, S. K., Syed, M., Dash, S., Wiese, T. E., Mandal, T. K., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.011 · Cited by 100
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Subramanian, N., Kanwar, J. R., Athalya, P. K., Janakiraman, N., Khetan, V., Kanwar, R. K., Eluchuri, S., & Krishnakumar, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-014-0108-9 · Cited by 99
Artificially Expanded Genetic Information Systems for New Aptamer Technologies
Biondi, E., & Benner, S. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020053 · Cited by 99
MUC-1 aptamer-conjugated dye-doped silica nanoparticles for MCF-7 cells detection
Cai, L., Chen, Z., Chen, M.-Y., Tang, H., & Pang, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.084 · Cited by 98
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1
Darfeuille, F. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh636 · Cited by 97
Zhao, N., Bagaria, H. G., Wong, M. S., & Zu, Y. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-2 · Cited by 97
Ayatollahi, S., Salmasi, Z., Hashemi, M., Askarian, S., Oskuee, R. K., Abnous, K., & Ramezani, M. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.005 · Cited by 96
GnRH Binding RNA and DNA Spiegelmers
Leva, S., Lichte, A., Burmeister, J., Muhn, P., Jahnke, B., Fesser, D., Erfurth, J., Burgstaller, P., & Klußmann, S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00111-4 · Cited by 95
Li, J., Wu, S., Wu, C. S., Qiu, L., Zhu, G., Cui, C., Liu, Y., Hou, W., Wang, Y., Zhang, L., et al. (2016) · Nanoscale · doi:10.1039/c6nr00600k · Cited by 95
Zhao, F., Zhou, J., Su, X., Wang, Y., Yan, X., Jia, S., & Du, B. (2017) · Small · doi:10.1002/smll.201603990 · Cited by 93
Identification and characterization of nucleobase-modified aptamers by click-SELEX
Pfeiffer, F., Tölle, F., Rosenthal, M., Brändle, G. M., Ewers, J., & Mayer, G. (2018) · Nature Protocols · doi:10.1038/nprot.2018.023 · Cited by 93
Dam, D. H. M., Culver, K. S. B., & Odom, T. W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4005657 · Cited by 92
Li, J., You, J., Dai, Y., Shi, M., Han, C., & Xu, K. (2014) · Analytical Chemistry · doi:10.1021/ac503026d · Cited by 92
Selection of 2′-Fluoro-Modified Aptamers with Optimized Properties
Thirunavukarasu, D., Chen, T., Liu, Z., Hongdilokkul, N., & Romesberg, F. E. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b13132 · Cited by 92
Wen, S., Miao, X., Fan, G., Xu, T., Jiang, L., Wu, P., Cai, C., & Zhu, J. (2019) · ACS Sensors · doi:10.1021/acssensors.8b00682 · Cited by 92
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Ortiz, B. L., Ghaghada, K. B., Volk, D. E., Nieves-Alicea, R., Suh, K. S., Mauro Ferrari, B., Annapragada, A., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.261 · Cited by 91
Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers
Kibler-Herzog, L., Zon, G., Uznański, B., Whittier, G., & Wilson, W. D. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.11.2979 · Cited by 91
Sayari, E., Dinarvand, M., Amini, M., Azhdarzadeh, M., Mollarazi, E., Ghasemi, Z., & Atyabi, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.041 · Cited by 90
Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers
Quang, N. N., Perret, G., & Ducongè, F. (2016) · Pharmaceuticals · doi:10.3390/ph9040076 · Cited by 87
Watts, J. K., Martín‐Pintado, N., Gómez‐Pinto, I., Schwartzentruber, J., Portella, G., Orozco, M., González, C., & Damha, M. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1225 · Cited by 85
Construction, Stability, and Activity of Multivalent Circular Anticoagulant Aptamers
Giusto, D. A. D., & King, G. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408037200 · Cited by 84
Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method
Hasegawa, H., Sode, K., & Ikebukuro, K. (2008) · Biotechnology Letters · doi:10.1007/s10529-007-9629-6 · Cited by 82
Modification of Aniline Containing Proteins Using an Oxidative Coupling Strategy
Hooker, J. M., Esser-Kahn, A. P., & Francis, M. B. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064088d · Cited by 81
Danesh, N. M., Lavaee, P., Ramezani, M., Abnous, K., & Taghdisi, S. M. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.072 · Cited by 81
Zhang, J., Chen, R., Fang, X., Chen, F., Wang, Y., & Chen, M. (2015) · Nano Research · doi:10.1007/s12274-014-0619-4 · Cited by 81
Taghdisi, S. M., Danesh, N. M., Lavaee, P., Emrani, A. S., Hassanabad, K. Y., Ramezani, M., & Abnous, K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.01.009 · Cited by 81
Tan, L., Neoh, K. G., Kang, E. T., Choe, W. S., & Su, X. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100173 · Cited by 80
Li, Z., Liu, Z., Yin, M., Yang, X., Yuan, Q., Ren, J., & Qu, X. (2012) · Biomacromolecules · doi:10.1021/bm301563q · Cited by 79
PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice
Pieve, C. D., Blackshaw, E., Missailidis, S., & Perkins, A. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300128r · Cited by 79
Pi, F., Zhang, H., Li, H., Thiviyanathan, V., Gorenstein, D. G., Sood, A. K., & Guo, P. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.015 · Cited by 78
An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells
Ara, M. N., Matsuda, T., Hyodo, M., Sakurai, Y., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.087 · Cited by 76
Ghasemi, Z., Dinarvand, R., Mottaghitalab, F., Esfandyari‐Manesh, M., Sayari, E., & Atyabi, F. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.025 · Cited by 76
In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
Ababneh, N. A., Alshaer, W., Al‐Louzi, O., Mahafzah, A. M., El-Khateeb, M. S., Hillaireau, H., Noiray, M., Fattal, E., & Ismail, S. I. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0423 · Cited by 76
Self-citationZhao, H., Fan, W., Hao, J., Wu, X., Zeng, G. Q., Zhang, L., Nie, S. F., & Wang, X. D. (2014) · Drug Delivery · doi:10.3109/10717544.2014.920059 · Cited by 76
A DNA Spiegelmer to staphylococcal enterotoxin B
Purschke, W. G. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg413 · Cited by 76
Moosavian, S. A., Abnous, K., Badiee, A., & Jaafari, M. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.009 · Cited by 76
Lin, Z., Ma, Q., Fei, X., Zhang, H., & Su, X. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.01.057 · Cited by 75
MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide
Charbgoo, F., Alibolandi, M., Taghdisi, S. M., Abnous, K., Soltani, F., & Ramezani, M. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.010 · Cited by 75
A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery
Leach, J., Wang, A., Ye, K., & Jin, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030380 · Cited by 72
Binding of a Structured D-RNA Molecule by an L-RNA Aptamer
Sczepanski, J. T., & Joyce, G. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406634g · Cited by 71
Ninomiya, K., Yamashita, T., Kawabata, S., & Shimizu, N. (2014) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.12.023 · Cited by 67
Studies on the hydrolytic stability of 2′-fluoroarabinonucleic acid (2′F-ANA)
Watts, J. K., Katolik, A., Viladoms, J., & Damha, M. J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b900443b · Cited by 67
In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
Wang, H., Zhang, Y., Yang, H., Qin, M., Ding, X., Liu, R., & Jiang, Y. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.12.003 · Cited by 67
Pilapong, C., Sitthichai, S., Thongtem, S., & Thongtem, T. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.036 · Cited by 66
Dressed for success – applying chemistry to modulate aptamer functionality
Tölle, F., & Mayer, G. (2012) · Chemical Science · doi:10.1039/c2sc21510a · Cited by 65
Behrooz, A. B., Nabavizadeh, F., Adiban, J., Ardestani, M. S., Vahabpour, R., Aghasadeghi, M. R., & Sohanaki, H. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12670 · Cited by 64
Belyanina, I. V., Zamay, T. N., Сергеевна, З. Г., Сергеевич, З. С., Kolovskaya, O. S., Ivanchenko, T. I., Денисенко, В. В., Кириченко, А. К., Glazyrin, Y. E., Garanzha, I. V., et al. (2017) · Theranostics · doi:10.7150/thno.17089 · Cited by 64
Lee, Y.-J., Urban, J. H., Xu, L., Sullenger, B. A., & Lee, J. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0575 · Cited by 63
C2′-Pyrene-Functionalized Triazole-Linked DNA: Universal DNA/RNA Hybridization Probes
Sau, S. P., & Hrdlicka, P. J. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo201845z · Cited by 61
Oligodeoxynucleotide Studies in Primates: Antisense and Immune Stimulatory Indications
Farman, C. A., & Kornbrust, D. J. (2003) · Toxicologic Pathology · doi:10.1080/01926230390174995 · Cited by 61
Mosafer, J., Teymouri, M., Abnous, K., Tafaghodi, M., & Ramezani, M. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.11.053 · Cited by 60
Aptamers as a model for functional evaluation of LNA and 2′-amino LNA
Hernández, F. J., Kalra, N., Wengel, J., & Vester, B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.039 · Cited by 60
Yu, S., Dong, R., Chen, J., Chen, F., Jiang, W., Zhou, Y., Zhu, X., & Yan, D. (2014) · Biomacromolecules · doi:10.1021/bm5002203 · Cited by 60
Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
Pala, K., Serwotka-Suszczak, A. M., Jeleń, F., Jakimowicz, P., & Otlewski, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52539 · Cited by 59
Cited by
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Self-citationsiRNA: Mechanism of action, challenges, and therapeutic approaches
Alshaer, W., Zureigat, H., Al Karaki, A., Al-Kadash, A., Gharaibeh, L., Hatmal, M. M., Aljabali, A. A. A., & Awidi, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174178 · Cited by 441
Self-citationDetection and beyond: challenges and advances in aptamer-based biosensors
Yoo, H., Jo, H., & Oh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00639d · Cited by 334
Recent progress in non-native nucleic acid modifications
McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300
Ma, W., Yang, Y., Zhu, J., Jia, W., Zhang, T., Liu, Z., Chen, X., & Lin, Y. (2022) · Advanced Materials · doi:10.1002/adma.202109609 · Cited by 300
Metadata
- Authors
- Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., Bawab, A. A., & Ismail, S. I.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-12-18
- Volume
- 25
- Issue
- 1
- Pages
- 3
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2995953990
- Cited by
- 415
- References
- 251
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.